Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

2017 Rating of Russian Pharmacy Chains

Thursday, February 22, 2018

At the beginning of the year, pharmaceutical drug sale in non-pharmaceutical stores was once again one of the central topics for the Russian pharmaceutical industry. The industry professionals made an unambiguous assessment of the initiative, which could have called it quits. However, the regulators had other ideas. In December 2017, a draft federal law was submitted for public discussion.

It is no secret that once a draft federal law has been submitted, it is very likely it will pass. That is why the statement of several large Russian pharmaceutical retailers about the risk of closing a significant share of their pharmacies seriously stirred up both the industry and the general public. If the industry leaders are at risk, then what will happen to the smaller companies?

The industry leaders are no less frightened, though, with the founder of the company Magnit Sergei Galitsky selling the blocking stake to the VTB bank. We are not going to start quoting the conspiracy theories about the start of the process of nationalization of the global retail market, as they do not seem true, but it is difficult to ignore the growing role of the banking sector in retail management, including pharmaceutical. In particular, the pharmacy chain 36.6 experienced significant changes in the management structure this year, some of which seem to have been initiated by Credit Bank of Moscow.

Tab 1. Top pharmaceutical chains, Russian market share in 2017